Finance

Lists
603229:SHA
Zhejiang Ausun Pharmaceutical Co Ltd
CNÂ¥7.52
-2.46%
(-0.19) 1D
Sep 11, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603229...
Open
CNÂ¥7.67
High
CNÂ¥7.72
Low
CNÂ¥7.45
Mkt. cap
6.40B
Avg. vol.
7.81M
Volume
6.33M
Dividend
0.85%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jul 17, 2026
P/E ratio
76.18
52-wk high
CNÂ¥12.06
52-wk low
CNÂ¥7.15
EPS
CNÂ¥0.10
Shares outstanding
160.00M
No. of employees
1K
Open
CNÂ¥7.67
High
CNÂ¥7.72
Low
CNÂ¥7.45
Mkt. cap
6.40B
Avg. vol.
7.81M
Volume
6.33M
Dividend
0.85%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jul 17, 2026
P/E ratio
76.18
52-wk high
CNÂ¥12.06
52-wk low
CNÂ¥7.15
EPS
CNÂ¥0.10
Shares outstanding
160.00M
No. of employees
1K
About Zhejiang Ausun Pharmaceutical Co Ltd
CEO-
Employees1.33K
FoundedApr 22, 2010
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
164.09M
146.80M
308.67M
158.94M
Cost of goods sold
74.64M
109.90M
116.10M
98.39M
Cost of revenue
74.64M
109.90M
116.10M
98.39M
Research and development expenses
25.28M
86.27M
30.76M
27.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.19M
43.63M
25.16M
28.30M
Operating expense
51.32M
122.51M
65.26M
46.00M
Total operating expenses
125.96M
232.42M
181.36M
144.38M
Operating income
38.13M
-85.62M
127.32M
14.56M
Other non operating income
-4.56M
4.51M
-24.03M
-22.56M
EBT including unusual items
38.67M
-95.44M
107.33M
22.96M
EBT excluding unusual items
38.79M
-91.98M
110.40M
-4.35M
Income tax expense
982.48K
-18.98M
10.67M
-214.34K
Effective tax rate
2.54%
19.89%
9.94%
-0.93%
Other operating expenses
1.65M
-1.11M
-1.44M
1.36M
Net income
37.69M
-76.46M
96.66M
23.18M
Net profit margin
22.97%
-52.09%
31.32%
14.58%
Earnings per share
-
-
-
-
Interest and investment income
11.95M
12.21M
9.94M
3.65M
Interest expense
-2.06M
-2.47M
-2.83M
-
Net interest expenses
9.89M
9.74M
7.12M
3.65M
Depreciation and amortization charges
-
-
-
-
EBITDA
53.77M
-67.40M
145.53M
35.53M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps